Privia Health Group, Inc. (NASDAQ:PRVA) Receives $30.50 Average Price Target from Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have received an average rating of “Moderate Buy” from the sixteen research firms that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $30.50.

Several analysts have commented on PRVA shares. Canaccord Genuity Group raised their price objective on Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, November 12th. Citizens Jmp increased their target price on Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a research report on Friday, November 7th. Evercore lifted their price target on shares of Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Stephens restated an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, December 4th. Finally, BMO Capital Markets began coverage on shares of Privia Health Group in a report on Thursday, November 13th. They set an “outperform” rating and a $30.00 price objective on the stock.

Privia Health Group Stock Up 4.1%

PRVA stock opened at $22.39 on Thursday. Privia Health Group has a 52-week low of $18.77 and a 52-week high of $26.51. The firm has a market cap of $2.75 billion, a P/E ratio of 172.24, a PEG ratio of 1.57 and a beta of 0.83. The company’s 50-day simple moving average is $23.37 and its 200-day simple moving average is $23.34.

Insider Activity

In other Privia Health Group news, Director Matthew Shawn Morris sold 13,647 shares of the stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $25.01, for a total transaction of $341,311.47. Following the completion of the transaction, the director owned 68,188 shares of the company’s stock, valued at $1,705,381.88. This represents a 16.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David Mountcastle sold 23,887 shares of the firm’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $25.03, for a total value of $597,891.61. Following the completion of the transaction, the chief financial officer owned 172,909 shares in the company, valued at approximately $4,327,912.27. This trade represents a 12.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 10.70% of the company’s stock.

Institutional Investors Weigh In On Privia Health Group

A number of large investors have recently modified their holdings of the business. Hantz Financial Services Inc. raised its position in shares of Privia Health Group by 456.2% in the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after buying an additional 926 shares during the last quarter. Global Retirement Partners LLC grew its stake in Privia Health Group by 579.8% during the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after acquiring an additional 1,351 shares in the last quarter. CWM LLC raised its holdings in Privia Health Group by 89.4% in the 2nd quarter. CWM LLC now owns 3,416 shares of the company’s stock valued at $79,000 after acquiring an additional 1,612 shares during the last quarter. Canada Pension Plan Investment Board lifted its stake in Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new position in Privia Health Group in the 4th quarter worth approximately $93,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.